US Stock MarketDetailed Quotes

TCRX TScan Therapeutics

Watchlist
  • 8.550
  • +0.260+3.14%
Close May 31 16:00 ET
  • 8.840
  • +0.290+3.39%
Post 16:04 ET
451.98MMarket Cap-11400P/E (TTM)

TScan Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-91.68%566K
55.52%21.05M
132.99%7.21M
15.58%3.89M
-22.39%3.15M
125.19%6.8M
33.47%13.54M
8.44%3.1M
39.43%3.36M
42.42%4.06M
Operating revenue
-91.68%566K
55.52%21.05M
132.99%7.21M
15.58%3.89M
-22.39%3.15M
125.19%6.8M
33.47%13.54M
8.44%3.1M
39.43%3.36M
42.42%4.06M
Cost of revenue
Gross profit
Operating expense
8.10%31.94M
42.83%114.51M
31.38%28.57M
43.60%28.64M
43.81%27.76M
54.01%29.55M
36.39%80.17M
27.49%21.74M
9.24%19.94M
42.69%19.3M
Selling and administrative expenses
-8.82%7.08M
29.49%26.35M
0.36%6.16M
20.04%5.89M
35.84%6.53M
72.83%7.77M
47.18%20.35M
38.04%6.14M
21.29%4.91M
76.38%4.81M
-General and administrative expense
-8.82%7.08M
29.49%26.35M
0.36%6.16M
20.04%5.89M
35.84%6.53M
72.83%7.77M
47.18%20.35M
38.04%6.14M
21.29%4.91M
76.38%4.81M
Research and development costs
14.13%24.86M
47.37%88.15M
43.59%22.41M
51.29%22.74M
46.45%21.23M
48.26%21.78M
33.07%59.82M
23.76%15.6M
5.81%15.03M
34.19%14.49M
Operating profit
-37.95%-31.37M
-40.25%-93.46M
-14.52%-21.36M
-49.28%-24.75M
-61.42%-24.61M
-40.71%-22.74M
-37.00%-66.64M
-31.31%-18.65M
-4.65%-16.58M
-42.77%-15.25M
Net non-operating interest income expense
583.89%1.23M
921.69%4.24M
2,456.76%1.74M
425.83%1.75M
279.19%565K
2,471.43%180K
2,493.75%415K
-3,800.00%-74K
11,000.00%333K
2,880.00%149K
Non-operating interest income
92.78%2.19M
402.77%8M
188.12%2.6M
411.80%2.73M
929.53%1.53M
16,128.57%1.14M
9,843.75%1.59M
44,950.00%901K
17,700.00%534K
2,880.00%149K
Non-operating interest expense
0.31%959K
219.64%3.76M
-12.62%852K
388.56%982K
--969K
--956K
--1.18M
--975K
--201K
--0
Other net income (expense)
Income before tax
-33.59%-30.14M
-34.73%-89.22M
-4.75%-19.61M
-41.56%-23M
-59.27%-24.05M
-39.66%-22.56M
-36.19%-66.22M
-31.85%-18.72M
-2.56%-16.25M
-41.44%-15.1M
Income tax
Net income
-33.59%-30.14M
-34.73%-89.22M
-4.75%-19.61M
-41.56%-23M
-59.27%-24.05M
-39.66%-22.56M
-36.19%-66.22M
-31.85%-18.72M
-2.56%-16.25M
-41.44%-15.1M
Net income continuous Operations
-33.59%-30.14M
-34.73%-89.22M
-4.75%-19.61M
-41.56%-23M
-59.27%-24.05M
-39.66%-22.56M
-36.19%-66.22M
-31.85%-18.72M
-2.56%-16.25M
-41.44%-15.1M
Minority interest income
Net income attributable to the parent company
-33.59%-30.14M
-34.73%-89.22M
-4.75%-19.61M
-41.56%-23M
-59.27%-24.05M
-39.66%-22.56M
-36.19%-66.22M
-31.85%-18.72M
-2.56%-16.25M
-41.44%-15.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-33.59%-30.14M
-34.73%-89.22M
-4.75%-19.61M
-41.56%-23M
-59.27%-24.05M
-39.66%-22.56M
-36.19%-66.22M
-31.85%-18.72M
-2.56%-16.25M
-41.44%-15.1M
Basic earnings per share
65.59%-0.32
50.55%-1.36
85.90%-0.11
64.18%-0.24
19.05%-0.51
-38.81%-0.93
34.05%-2.75
-31.32%-0.78
16.25%-0.67
-38.83%-0.63
Diluted earnings per share
65.59%-0.32
50.55%-1.36
85.90%-0.11
64.18%-0.24
19.05%-0.51
-38.81%-0.93
34.05%-2.75
-31.32%-0.78
16.25%-0.67
-38.83%-0.63
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -91.68%566K55.52%21.05M132.99%7.21M15.58%3.89M-22.39%3.15M125.19%6.8M33.47%13.54M8.44%3.1M39.43%3.36M42.42%4.06M
Operating revenue -91.68%566K55.52%21.05M132.99%7.21M15.58%3.89M-22.39%3.15M125.19%6.8M33.47%13.54M8.44%3.1M39.43%3.36M42.42%4.06M
Cost of revenue
Gross profit
Operating expense 8.10%31.94M42.83%114.51M31.38%28.57M43.60%28.64M43.81%27.76M54.01%29.55M36.39%80.17M27.49%21.74M9.24%19.94M42.69%19.3M
Selling and administrative expenses -8.82%7.08M29.49%26.35M0.36%6.16M20.04%5.89M35.84%6.53M72.83%7.77M47.18%20.35M38.04%6.14M21.29%4.91M76.38%4.81M
-General and administrative expense -8.82%7.08M29.49%26.35M0.36%6.16M20.04%5.89M35.84%6.53M72.83%7.77M47.18%20.35M38.04%6.14M21.29%4.91M76.38%4.81M
Research and development costs 14.13%24.86M47.37%88.15M43.59%22.41M51.29%22.74M46.45%21.23M48.26%21.78M33.07%59.82M23.76%15.6M5.81%15.03M34.19%14.49M
Operating profit -37.95%-31.37M-40.25%-93.46M-14.52%-21.36M-49.28%-24.75M-61.42%-24.61M-40.71%-22.74M-37.00%-66.64M-31.31%-18.65M-4.65%-16.58M-42.77%-15.25M
Net non-operating interest income expense 583.89%1.23M921.69%4.24M2,456.76%1.74M425.83%1.75M279.19%565K2,471.43%180K2,493.75%415K-3,800.00%-74K11,000.00%333K2,880.00%149K
Non-operating interest income 92.78%2.19M402.77%8M188.12%2.6M411.80%2.73M929.53%1.53M16,128.57%1.14M9,843.75%1.59M44,950.00%901K17,700.00%534K2,880.00%149K
Non-operating interest expense 0.31%959K219.64%3.76M-12.62%852K388.56%982K--969K--956K--1.18M--975K--201K--0
Other net income (expense)
Income before tax -33.59%-30.14M-34.73%-89.22M-4.75%-19.61M-41.56%-23M-59.27%-24.05M-39.66%-22.56M-36.19%-66.22M-31.85%-18.72M-2.56%-16.25M-41.44%-15.1M
Income tax
Net income -33.59%-30.14M-34.73%-89.22M-4.75%-19.61M-41.56%-23M-59.27%-24.05M-39.66%-22.56M-36.19%-66.22M-31.85%-18.72M-2.56%-16.25M-41.44%-15.1M
Net income continuous Operations -33.59%-30.14M-34.73%-89.22M-4.75%-19.61M-41.56%-23M-59.27%-24.05M-39.66%-22.56M-36.19%-66.22M-31.85%-18.72M-2.56%-16.25M-41.44%-15.1M
Minority interest income
Net income attributable to the parent company -33.59%-30.14M-34.73%-89.22M-4.75%-19.61M-41.56%-23M-59.27%-24.05M-39.66%-22.56M-36.19%-66.22M-31.85%-18.72M-2.56%-16.25M-41.44%-15.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -33.59%-30.14M-34.73%-89.22M-4.75%-19.61M-41.56%-23M-59.27%-24.05M-39.66%-22.56M-36.19%-66.22M-31.85%-18.72M-2.56%-16.25M-41.44%-15.1M
Basic earnings per share 65.59%-0.3250.55%-1.3685.90%-0.1164.18%-0.2419.05%-0.51-38.81%-0.9334.05%-2.75-31.32%-0.7816.25%-0.67-38.83%-0.63
Diluted earnings per share 65.59%-0.3250.55%-1.3685.90%-0.1164.18%-0.2419.05%-0.51-38.81%-0.9334.05%-2.75-31.32%-0.7816.25%-0.67-38.83%-0.63
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg